17Beta-oestradiol up-regulates the expression of a functional UDP-glucose dehydrogenase in articular chondrocytes: comparison with effects of cytokines and growth factors.
OBJECTIVE
To investigate the mechanisms by which cytokines and 17beta-oestradiol (17beta-E2) modulate gene expression and activity of uridine diphosphoglucose dehydrogenase (UGDH), a key enzyme of GAG synthesis in articular chondrocytes.


METHODS
Rabbit articular chondrocytes (RAC) from 3-week-old animals were incubated for 24 h with TGF-beta, insulin like growth factor-I (IGF-I), IL-1beta, IL-6 and 17beta-E2. GAG synthesis was measured by [35S]-sulphate labelling and the expression of the UGDH gene was estimated by both real-time polymerase chain reaction and western blotting, whereas the enzyme activity was assayed by a spectrophotometric procedure. In addition, the transcriptional activity of several UGDH gene promoter constructs was determined in RAC transiently transfected with wild-type or deleted human oestrogen receptor-alpha gene (hER alpha66 or hER alpha46, respectively).


RESULTS
17Beta-E2 and its receptor hER alpha66 enhanced GAG neosynthesis in rabbit articular chondrocytes, as did TGF-beta1 whereas IL-1beta decreased this synthesis. 17Beta-E2 was found to exert positive regulatory effects at mRNA, protein and UGDH activity levels. In addition, the receptor hER alpha66, but not hER alpha46, increased the transcriptional activity of the UGDH gene. In contrast, no clear correlation between transcription, translation and activity of the UGDH was found under the effects of the cytokines studied. However, TGF-beta enhanced the enzyme activity, whereas IL-1beta, IL-6 and IGF-I were without significant effect.


CONCLUSIONS
17Beta-E2 enhanced GAG synthesis in chondrocytes via up-regulation of the UGDH gene expression and enzyme activity. These data provide insights into the molecular mechanisms involved in the regulation of the UGDH gene and offer new approaches to investigate its potential alteration in joint diseases.
Maneix
L
L
Laboratory of Extracellular Matrix and Pathology, Faculty of Medicine, IFR 146 ICORE, University of Caener-Low Normandy, Caen, France.
Beauchef
G
G
Servent
A
A
Wegrowski
Y
Y
Maquart
F X
FX
Boujrad
N
N
Flouriot
G
G
Pujol
J P
JP
Boumediene
K
K
Galéra
P
P
Moslemi
S
S
D000818:Animals; D000831:Animals, Newborn; D015153:Blotting, Western; D002358:Cartilage, Articular / Q000166:cytology; D002478:Cells, Cultured; D019902:Chondrocytes / Q000187:drug effects* / Q000378:metabolism; D016207:Cytokines / Q000494:pharmacology; D004195:Disease Models, Animal; D004958:Estradiol / Q000494:pharmacology*; D005786:Gene Expression Regulation; D008297:Male; D012333:RNA, Messenger / Q000032:analysis; D011817:Rabbits; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012680:Sensitivity and Specificity; D016212:Transforming Growth Factor beta / Q000494:pharmacology; D015854:Up-Regulation; D014533:Uridine Diphosphate Glucose Dehydrogenase / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism*
D016207:Cytokines; D012333:RNA, Messenger; D016212:Transforming Growth Factor beta; D004958:Estradiol; D014533:Uridine Diphosphate Glucose Dehydrogenase